No peeler needed here! Keeping the skin on adds flecks of color and a hearty texture to these mashed red potatoes. Marcia Kiesel, a former Food & Wine test kitchen supervisor, is an experienced chef ...

For years, food magazines have preached the many wonders of Yukon Gold potatoes. They told us Golds were the superior spud—the only potato worth mashing. They made us feel like a fool for even ...

I was as surprised as anyone to find myself on a Saturday afternoon in October doing a mashed potato science experiment. The journey started just before Thanksgiving last year, when my sister and I ...

Use russet potatoes if you prefer mashed potatoes with a traditional fluffy texture that easily absorb additions like butter. Opt for Yukon Gold potatoes if you want creamier mashed potatoes and an ...

The scientists at Miramax have apparently been working in the lab late at night coming up with an idea for an eerie sight. And what they’ve come up with is adapting someone else’s. The studio is ...

EXCLUSIVE: The 1962 song “Monster Mash,” which has become an annual Halloween +hit, is becoming an animated movie at Miramax. Miramax CEO Jonathan Glickman, who has been behind such haunted hits as ...

“Monster Mash” by Bobby “Boris” Pickett and the Crypt-Kickers has just been crowned the biggest Halloween song of all time by Billboard! The iconic hit was first released in August 1962, and spent two ...

For years, MASH was where drug development dreams went to die. One trial after another failed. Companies bowed out. The field earned a reputation as one of biopharma’s most intractable challenges: a ...

Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

Hall of Fame quarterback Dan Marino recently revealed that he was diagnosed with metabolic dysfunction-associated steatohepatitis, or MASH. The Miami Dolphins legend said the discovery came years ago ...

There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...